Medically reviewed by Archana Sharma, DO NSCLC starts in the lungs, but when it metastasizes, it spreads to other body ...

Risk of non-small cell lung cancer (NSCLC), a malignancy that develops in the tissues of the lung, increases considerably ...

The majority of patients with lung cancer are diagnosed at an advanced stage, with a substantial proportion exhibiting signs of brain metastases (BMs). BM is associated with debilitating symptoms, ...

Patients with previously untreated advanced squamous non-small-cell lung cancer lived significantly longer without their ...

The two main categories for lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Large cell lung cancer (LCLC) is a type of NSCLC. While the conditions share some ...

An experimental antibody treatment that binds to a protein known as PCDH7 shrank tumors in preclinical models of non-small ...

Stereotactic ablative radiotherapy (SABR) offers patients with early-stage non-small cell lung cancer (NSCLC) an effective alternative to the standard of care surgery — with significantly fewer severe ...

Following another phase 3 failure for Gilead Sciences’ Trodelvy, the race to bring a TROP2 antibody-drug conjugate (ADC) to patients with first-line non-small cell lung cancer (NSCLC) has narrowed. | ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...

FDA grants Fast Track designation to VS-7375, an oral investigational KRAS G12D inhibitor, for locally advanced or metastatic ...

Lung cancer took tech executive Susan Wojcicki's life. Now her family has started a foundation as a “catalyst for change.” ...